FDA Adverse Event Malfunction Summary report: N

INRATIO

MDR report key: 727473 · Received June 9, 2006

Report

Report Number
2954730-2006-00347
Event Type
Malfunction
Date Received
June 9, 2006
Date of Event
May 31, 2006
Report Date
June 7, 2006
Manufacturer
HEMOSENSE, INC.
Product Code
JPA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
UNKNOWN

Narratives

Additional Manufacturer Narrative · 1

INRATIO PRECISION DATA PROVIDED BY END-USER LOT 050435: 05/31/06 FIRST TEST INR = 7.1 SECOND TEST INR = 5.1, MEAN = 6.1; SD = 1.4; %CV = 23%. THE %CV IS GREATER 20%. PER INTERNAL PROCEDURE, TR 0150, THE PRECISION FAILED THE CRITERIA FOR PREVISION. RETAIN STRIPS WILL BE INVESTIGATED. RESULTS OF TESTS PERFORMED ON 4/12/2006: PT #1 - NORMAL, 050435 RETAINS = 1.0, PT #2 NORMAL, 050435 RETAINS = 0.9, PT #1 - NORMAL, 050435 RETAINS = 0.9, PT #2 NORMAL, 050435 RETAINS = 0.9, PT #1 MEAN, 050435 RETAINS = 0.95, PT #2 MEAN 0.9; PT #1: SD, 050435 = 0.07, PT #2: SD, 050435 RETAINS = 0.00, PT #1: %CV 050435 RETAIN = 7.4%, PT #2: %CV, 050435 RETAIN = 0.0%. PER PR 130, LOT 050435 PASSES THE CRITERIA FOR PRECISION. CASE UPDATED BY TS ON 06/02/06. DATE: 06/02/06, INRATIO = 4.6, LAB = 5.3, MEAN = 4.95, CONFIDENCE LIMITS = 2.8-7.2 PER INTERNAL PROCEDURE, TR 0150, THE CALCULATED MEAN OF THE INRATIO METER AND COMPARATIVE SYSTEM INR WERE CALCULATED. BOTH INRATIO AND LAB VALUES ARE WITHIN THE CONFIDENCE LIMITS FOR INR TESTING. THE RESULTS ARE NOT CONSIDERED DISCREPANT WITHIN THE CONTEXT OF THE DOCUMENTED VARIABILITY FOR INR TESTING. THEREFORE FURTHER TESTING IS NOT REQUIRED AT THIS TIME.

Description of Event or Problem · 1

CALLER ALLEGED IMPRECISION RESULTS WITH INRATIO. RESULTS AS FOLLOWS: 05/31/06 FIRST TEST INR = 7.1 SECOND TEST INR = 5.1. CASE UPDATED BY TECHNICAL SUPPORT ON 06/02/06. CALLER ALLEGED DISCREPANT RESULTS COMPARED WITH THE LAB. RESULTS AS FOLLOWS: DATE 06/02/06 INRATIO=4.6, LAB=5.3

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 INRATIO PROTHROMBIN TIME TEST JPA HEMOSENSE, INC. * 050435

Patients

Seq Age Sex Outcome Treatment
1 *